View in EDS

Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics.

Saved in:
Bibliographic Details
Title: Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics.
Authors: Lozano-Rabella M; Tumor Immunology and Immunotherapy, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Garcia-Garijo A; Tumor Immunology and Immunotherapy, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Palomero J; Tumor Immunology and Immunotherapy, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Yuste-Estevanez A; Tumor Immunology and Immunotherapy, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Erhard F; Institute for Virology and Immunobiology, University of Würzburg, Würzburg, Germany., Farriol-Duran R; Tumor Immunology and Immunotherapy, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Martín-Liberal J; Early Drug Development Unit (UITM) Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital, Barcelona, Spain., Ochoa-de-Olza M; Early Drug Development Unit (UITM) Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital, Barcelona, Spain., Matos I; Early Drug Development Unit (UITM) Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital, Barcelona, Spain., Gartner JJ; Surgery Branch, National Cancer Institute (NCI), National Institutes of Health, Bethesda, Maryland., Ghosh M; Institute for Cell Biology Department of Immunology, University of Tübingen, Tübingen, Germany., Canals F; Proteomics, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital, Barcelona, Spain., Vidal A; Department of Pathology. Hospital Universitari de Bellvitge-IDIBELL, CIBERONC, Barcelona, Spain., Piulats JM; Medical Oncology, Catalan Institute of Cancer (ICO), IDIBELL-Oncobell, Hospitalet de Llobregat, Spain., Matías-Guiu X; Department of Pathology. Hospital Universitari de Bellvitge-IDIBELL, CIBERONC, Barcelona, Spain., Brana I; Early Drug Development Unit (UITM) Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital, Barcelona, Spain., Muñoz-Couselo E; Melanoma and other skin tumors unit, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital, Barcelona, Spain., Garralda E; Early Drug Development Unit (UITM) Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital, Barcelona, Spain., Schlosser A; Rudolf Virchow Center, Center for Integrative and Translational Bioimaging, Julius-Maximilians-University Würzburg, Würzburg, Germany., Gros A; Tumor Immunology and Immunotherapy, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Jun 13; Vol. 29 (12), pp. 2250-2265.
Publication Type: Editorial; Research Support, Non-U.S. Gov't; Comment
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36749875
AccessLevel: 2
PubType: Report
PubTypeId: report
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lozano-Rabella+M%22">Lozano-Rabella M</searchLink>; Tumor Immunology and Immunotherapy, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Garcia-Garijo+A%22">Garcia-Garijo A</searchLink>; Tumor Immunology and Immunotherapy, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Palomero+J%22">Palomero J</searchLink>; Tumor Immunology and Immunotherapy, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Yuste-Estevanez+A%22">Yuste-Estevanez A</searchLink>; Tumor Immunology and Immunotherapy, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Erhard+F%22">Erhard F</searchLink>; Institute for Virology and Immunobiology, University of Würzburg, Würzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Farriol-Duran+R%22">Farriol-Duran R</searchLink>; Tumor Immunology and Immunotherapy, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Martín-Liberal+J%22">Martín-Liberal J</searchLink>; Early Drug Development Unit (UITM) Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Ochoa-de-Olza+M%22">Ochoa-de-Olza M</searchLink>; Early Drug Development Unit (UITM) Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Matos+I%22">Matos I</searchLink>; Early Drug Development Unit (UITM) Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Gartner+JJ%22">Gartner JJ</searchLink>; Surgery Branch, National Cancer Institute (NCI), National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Ghosh+M%22">Ghosh M</searchLink>; Institute for Cell Biology Department of Immunology, University of Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Canals+F%22">Canals F</searchLink>; Proteomics, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Vidal+A%22">Vidal A</searchLink>; Department of Pathology. Hospital Universitari de Bellvitge-IDIBELL, CIBERONC, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Piulats+JM%22">Piulats JM</searchLink>; Medical Oncology, Catalan Institute of Cancer (ICO), IDIBELL-Oncobell, Hospitalet de Llobregat, Spain.<br /><searchLink fieldCode="AU" term="%22Matías-Guiu+X%22">Matías-Guiu X</searchLink>; Department of Pathology. Hospital Universitari de Bellvitge-IDIBELL, CIBERONC, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Brana+I%22">Brana I</searchLink>; Early Drug Development Unit (UITM) Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Muñoz-Couselo+E%22">Muñoz-Couselo E</searchLink>; Melanoma and other skin tumors unit, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Garralda+E%22">Garralda E</searchLink>; Early Drug Development Unit (UITM) Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Schlosser+A%22">Schlosser A</searchLink>; Rudolf Virchow Center, Center for Integrative and Translational Bioimaging, Julius-Maximilians-University Würzburg, Würzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Gros+A%22">Gros A</searchLink>; Tumor Immunology and Immunotherapy, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229502500%22">Clinical cancer research : an official journal of the American Association for Cancer Research</searchLink> [Clin Cancer Res] 2023 Jun 13; Vol. 29 (12), pp. 2250-2265.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Editorial; Research Support, Non-U.S. Gov't; Comment
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502500 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1557-3265 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210780432%22">10780432 </searchLink><i>NLM ISO Abbreviation: </i>Clin Cancer Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36749875
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/1078-0432.CCR-22-3298
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2250
    Titles:
      – TitleFull: Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lozano-Rabella M
      – PersonEntity:
          Name:
            NameFull: Garcia-Garijo A
      – PersonEntity:
          Name:
            NameFull: Palomero J
      – PersonEntity:
          Name:
            NameFull: Yuste-Estevanez A
      – PersonEntity:
          Name:
            NameFull: Erhard F
      – PersonEntity:
          Name:
            NameFull: Farriol-Duran R
      – PersonEntity:
          Name:
            NameFull: Martín-Liberal J
      – PersonEntity:
          Name:
            NameFull: Ochoa-de-Olza M
      – PersonEntity:
          Name:
            NameFull: Matos I
      – PersonEntity:
          Name:
            NameFull: Gartner JJ
      – PersonEntity:
          Name:
            NameFull: Ghosh M
      – PersonEntity:
          Name:
            NameFull: Canals F
      – PersonEntity:
          Name:
            NameFull: Vidal A
      – PersonEntity:
          Name:
            NameFull: Piulats JM
      – PersonEntity:
          Name:
            NameFull: Matías-Guiu X
      – PersonEntity:
          Name:
            NameFull: Brana I
      – PersonEntity:
          Name:
            NameFull: Muñoz-Couselo E
      – PersonEntity:
          Name:
            NameFull: Garralda E
      – PersonEntity:
          Name:
            NameFull: Schlosser A
      – PersonEntity:
          Name:
            NameFull: Gros A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 13
              M: 06
              Text: 2023 Jun 13
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1557-3265
          Numbering:
            – Type: volume
              Value: 29
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: Clinical cancer research : an official journal of the American Association for Cancer Research
              Type: main
ResultId 1